# A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis

> **NCT03710681** · PHASE1 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 16 (estimated)

## Conditions studied

- Moderate-to-severe Plaque Psoriasis

## Interventions

- **BIOLOGICAL:** SHR-1314

## Key facts

- **NCT ID:** NCT03710681
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-02
- **Primary completion:** 2019-04-21
- **Final completion:** 2019-07-30
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2018-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03710681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03710681, "A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03710681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*